Komori
Treasury Shares6090Human Metabolome Technologies,Inc.Information and Communications, Services and Others

Notice Regarding the Status of Share Repurchases

During May 2025, the Company acquired 64,100 common shares through market purchases. Cumulative acquisitions based on a resolution of the Board of Directors totaled 184,200 shares, with an acquisition cost of ¥131,273,200.

Worth reading
52Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
48650600
¥
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Market purchases on the Tokyo Stock Exchange

Resolved 14 May 2025 / Acquisition period 2025年2月14日~2025年12月31日

61.4%
Cumulative utilization rate
Limit115,800 株 remaining
Number of Shares300,000 shares (maximum)
52.5%
Cumulative utilization rate
LimitShares 61.4%118,726,800 円 remaining
Amount2億50百万円(上限)
33.1%
経過
Deadline214 days remaining
Period2025年2月14日~2025年12月31日

The darker band is the portion acquired this time (2025年5月1日から2025年5月31日(約定ベース)). At this pace, the share-count limit will be reached first, and the acquisition will end without using the full monetary limit.

Number of Shares
Limit300,000 shares (maximum)
Cumulative total184,200株(2025年5月31日時点)
Current64,100株
Amount
Limit2億50百万円(上限)
Cumulative total131,273,200円(2025年5月31日時点)
Current48,650,600円
Percentage of total issued shares5.1% (as a percentage of the total number of issued shares excluding treasury shares)
Average acquisition price for this transaction (calculated)¥759 per shareCurrent acquisition price ÷ current number of shares acquired

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。 Elapsed time is counted against the acquisition period set in the resolution, as of 05/31/2025. 約定ベース=売買が成立した日を基準に数えた数字です。受け渡しの日ではありません。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction64,100株
Total current acquisition price48,650,600円
Acquisition date/acquisition period2025年5月1日から2025年5月31日(約定ベース)
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired184,200株(2025年5月31日時点)
Cumulative acquisition cost131,273,200円(2025年5月31日時点)
Resolution date14 May 2025
Maximum number of shares to be acquired300,000 shares (maximum)
Total acquisition price2億50百万円(上限)
Acquisition period under the resolution2025年2月14日~2025年12月31日
Percentage of total issued shares5.1% (as a percentage of the total number of issued shares excluding treasury shares)
Items this document does not state (2)
Whether acquisition has been completedAverage Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The disclosure states that the treasury share repurchases were conducted pursuant to the company's Articles of Incorporation, based on Article 165, Paragraph 2 of the Companies Act, but does not provide a specific reason for the repurchases.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases | Human Metabolome Technologies,Inc. (6090) timely disclosure | Komori